“Sudhin Biopharma Company became familiar with ARMI during several networking meetings at NIIMBL and heard your CTO, Thomas Bollenbach, speak about ARMI at the conference on the “Business of Regenerative Medicine” at U Penn Medicine last summer, 2018,” said Dhinakar Kompala, Founder & CEO, adding “We discussed the benefits of joining ARMI with Tom and are now glad to become a new member.”
Sudhin Biopharma is an early-stage Biopharma technology development company located in Superior, CO, founded in 2014 by Prof. Dhinakar Kompala, after taking early retirement from his faculty position in the department of Chemical and Biological Engineering at the University of Colorado, Boulder.
“Sudhin Biopharma hopes to gain deeper understanding of the critical issues in regenerative medicine through its membership in ARMI and participation in its technical meetings. We hope to collaborate with ARMI member companies and develop novel manufacturing strategies for organoids using our single use disposable BioSettler during their harvest, washing and concentration operations. We will seek funding from ARMI for such collaborative projects with other ARMI members,” Dhinakar explained.
[ARMI | BioFabUSA and NIIMBL are Manufacturing USA institutes.]